The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
<emph type="ital">Ginkgo biloba</emph> for Preventing Cognitive Decline in Older Adults<subtitle>A Randomized Trial</subtitle>
Open accessAbstract
CONTEXT: The herbal product Ginkgo biloba is taken frequently with the intention of improving cognitive health in aging. However, evidence from adequately powered clinical trials is lacking regarding its effect on long-term cognitive functioning. OBJECTIVE: To determine whether G. biloba slows the rates of global or domain-specific cognitive decline in older adults. DESIGN, SETTING, AND PARTICIPANTS: The Ginkgo Evaluation of Memory (GEM) study, a randomized, double-blind, placebo-controlled clinical trial of 3069 community-dwelling participants aged 72 to 96 years, conducted in 6 academic medical centers in the United States between 2000 and 2008, with a median follow-up of 6.1 years. INTERVENTION: Twice-daily dose of 120-mg extract of G. biloba (n = 1545) or identical-appearing placebo (n = 1524). MAIN OUTCOME MEASURES: Rates of change over time in the Modified Mini-Mental State Examination (3MSE), in the cognitive subscale of the Alzheimer Disease Assessment Scale (ADAS-Cog), and in neuropsychological domains of memory, attention, visual-spatial construction, language, and executive functions, based on sums of z scores of individual tests. RESULTS: Annual rates of decline in z scores did not differ between G. biloba and placebo groups in any domains, including memory (0.043; 95% confidence interval [CI], 0.034-0.051 vs 0.041; 95% CI, 0.032-0.050), attention (0.043; 95% CI, 0.037-0.050 vs 0.048; 95% CI, 0.041-0.054), visuospatial abilities (0.107; 95% CI, 0.097-0.117 vs 0.118; 95% CI, 0.108-0.128), language (0.045; 95% CI, 0.037-0.054 vs 0.041; 95% CI, 0.033-0.048), and executive functions (0.092; 95% CI, 0.086-0.099 vs 0.089; 95% CI, 0.082-0.096). For the 3MSE and ADAS-Cog, rates of change varied by baseline cognitive status (mild cognitive impairment), but there were no differences in rates of change between treatment groups (for 3MSE, P = .71; for ADAS-Cog, P = .97). There was no significant effect modification of treatment on rate of decline by age, sex, race, education, APOE*E4 allele, or baseline mild cognitive impairment (P > .05). CONCLUSION: Compared with placebo, the use of G. biloba, 120 mg twice daily, did not result in less cognitive decline in older adults with normal cognition or with mild cognitive impairment. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00010803.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Encyclopedia of Psychology, Vol. 3. · doi:10.1037/10518-009 · Cited by 19,744
Validity of the Trail Making Test as an Indicator of Organic Brain Damage
Reitan, R. M. (1958) · Perceptual and Motor Skills · doi:10.2466/pms.1958.8.3.271 · Cited by 7,928
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Barnes, P. M., Bloom, B., & Nahin, R. L. (2008) · PsycEXTRA Dataset · doi:10.1037/e623942009-001 · Cited by 3,147
(1987) · PubMed · Cited by 2,657
A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary
Selnes, O. A. (1991) · Neurology · doi:10.1212/wnl.41.11.1856-a · Cited by 2,252
Telephone Interview for Cognitive Status
Brandt, J., Spencer, M., & Folstein, M. (2022) · PsycTESTS Dataset · doi:10.1037/t28542-000 · Cited by 1,474
California Verbal Learning Test
Delis, D. C., Freeland, J., Kramer, J. H., & Kaplan, E. (2016) · PsycTESTS Dataset · doi:10.1037/t48844-000 · Cited by 1,319
Rapp, S. R., Espeland, M. A., Shumaker, S. A., Henderson, V. W., Brunner, R. L., Manson, J. E., Gass, M. L. S., Stefanick, M. L., Lane, D. S., Hays, J., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2663 · Cited by 930
DeKosky, S. T. (2008) · JAMA · doi:10.1001/jama.2008.683 · Cited by 670
Ginkgo biloba for cognitive impairment and dementia
Birks, J., & Grimley Evans, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003120.pub3 · Cited by 581
Inhibition of amyloid-β aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761
Luo, Y., Smith, J. V., Paramasivam, V., Burdick, A., Curry, K. J., Buford, J. P., Khan, I., Netzer, W. J., Xu, H., & Butko, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182425199 · Cited by 398
Wesnes, K. A., Ward, T., McGinty, A., & Petrini, O. (2000) · Psychopharmacology · doi:10.1007/s002130000533 · Cited by 304
Ginkgo for Memory Enhancement: A Randomized Controlled Trial
Solomon, P. R., Adams, F., Silver, A., Zimmer, J., & DeVeaux, R. (2002) · JAMA · doi:10.1001/jama.288.7.835 · Cited by 269
Kennedy, D. O., Scholey, A. B., & Wesnes, K. A. (2000) · Psychopharmacology · doi:10.1007/s002130000501 · Cited by 255
Pietri, S., Maurelli, E., Drieu, K., & Culcasi, M. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0316 · Cited by 235
Neuropsychological characteristics of mild cognitive impairment subgroups
Lopez, O. L. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.045567 · Cited by 197
DeKosky, S. T., Fitzpatrick, A., Ives, D. G., Saxton, J., Williamson, J., Lopez, O. L., Burke, G., Fried, L., Kuller, L. H., Robbins, J., et al. (2006) · Contemporary Clinical Trials · doi:10.1016/j.cct.2006.02.007 · Cited by 176
Self-citationDoraiswamy, P. M., Bieber, F., Kaiser, L., Krishnan, K. R., Reuning-Scherer, J., & Gulanski, B. (1997) · Neurology · doi:10.1212/wnl.48.6.1511 · Cited by 165
DONGEN, M. C. J. M. V. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00003-9 · Cited by 164
Ginkgo Biloba for cognitive impairment and dementia
Birks, J., & Evans, J. G. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003120 · Cited by 163
A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline
Dodge, H. H., Zitzelberger, T., Oken, B., Howieson, D. B., & Kaye, J. A. (2008) · Neurology · doi:10.1212/01.wnl.0000303814.13509.db · Cited by 162
Statins and cognitive function in the elderly: The Cardiovascular Health Study
Bernick, C., Katz, R., Smith, N. L., Rapp, S., Bhadelia, R., Carlson, M., & Kuller, L. (2005) · Neurology · doi:10.1212/01.wnl.0000182897.18229.ec · Cited by 158
Disparities in cognitive functioning by race/ethnicity in the Baltimore Memory Study.
Schwartz, B. S., Glass, T. A., Bolla, K. I., Stewart, W. F., Glass, G. E., Rasmussen, M., Bressler, J. P., Shi, W., & Bandeen‐Roche, K. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.6727 · Cited by 149
Normal Rates of Forgetting of Verbal and Non-Verbal Material in Alzheimer's Disease
Becker, J. T., Boller, F., Saxton, J. A., & McGonigle-Gibson, K. L. (1987) · Cortex · doi:10.1016/s0010-9452(87)80019-9 · Cited by 145
Normative Data on the Boston Naming Test and Two Equivalent 30-Item Short Forms
Saxton, J. A., Ratcliff, G. G., Munro, C. A., Coffey, E. C., Becker, J. T., Fried, L. P., & Kuller, L. H. (2000) · The Clinical Neuropsychologist · doi:10.1076/clin.14.4.526.7204 · Cited by 134
Comprehensive and Neuropsychologic Evaluations
Mohs, R. C. (1996) · International Psychogeriatrics · doi:10.1017/s1041610296002578 · Cited by 106
Huang, S., Jeng, C., Kao, S.-C., Yu, J. J.-H., & Liu, D.-Z. (2003) · Clinical Nutrition · doi:10.1016/j.clnu.2003.10.010 · Cited by 90
EXTRACTS OF GINKGO BILOBA AND GINSENOSIDES EXERT CEREBRAL VASORELAXATION VIA A NITRIC OXIDE PATHWAY
Chen, X., Salwinski, S., & Lee, T. (1997) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1997.tb02727.x · Cited by 87
Fitzpatrick, A. L., Fried, L. P., Williamson, J. D., Crowley, P., Posey, D., Kwong, L., Bonk, J., Moyer, R., Chabot, J., Kidoguchi, L., et al. (2006) · Contemporary Clinical Trials · doi:10.1016/j.cct.2006.06.007 · Cited by 80
Effect of two doses of ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects.
Allain, H., Raoul, P., Lieury, A., Coz, F. L., Gandon, J. M., & D’Arbigny, P. (1993) · PubMed · Cited by 77
Kaschel, R. (2009) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1037 · Cited by 61
α2-Adrenoceptor Changes During Cerebral Ageing. The Effect ofGinkgo bilobaExtract
Huguet, F., & Tarrade, T. (1992) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1992.tb14357.x · Cited by 60
Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study
Snitz, B. E., Saxton, J. A., López, O. L., Ives, D. G., Dunn, L. O., Rapp, S. R., Carlson, M. C., Fitzpatrick, A. L., DeKosky, S. T., & for the GEM study Investigators (2009) · Aging & Mental Health · doi:10.1080/13607860802380656 · Cited by 24
Self-citationNational Center for Complementary and Alternative Medicine
(2003) · Hepatology · doi:10.1002/hep.510370303 · Cited by 24
Activity of Ginkgo Biloba Extract on Short-Term Memory
Hindmarch, I. (1988) · Springer eBooks · doi:10.1007/978-3-642-73686-5_36 · Cited by 23
Effect of Ginkgo biloba extract on β‐adrenergic receptors in different rat brain regions
Hadjiivanova, C., & Petkov, V. V. (2002) · Phytotherapy Research · doi:10.1002/ptr.933 · Cited by 20
Cited by
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336
The Diagnosis and Management of Mild Cognitive Impairment: A Clinical Review
Langa, K. M., & Levine, D. A. (2014) · JAMA · doi:10.1001/jama.2014.13806 · Cited by 1,337
Kamat, P. K., Kalani, A., Rai, S., Swarnkar, S., Tota, S., Nath, C., & Tyagi, N. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9053-6 · Cited by 500
Sanford, A. M. (2017) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2017.02.005 · Cited by 436
Metadata
- Authors
- Snitz, B. E.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2009-12-23
- Volume
- 302
- Issue
- 24
- Pages
- 2663
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2156220503
- Cited by
- 336
- References
- 39
- FWCI
- 63.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.